Business Context and Reporting Period
Company: Universal Display Corporation (Universal Display Corp)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and nine months ended September 30, 2008
Business Overview: The Company is engaged in the research, development, and commercialization of organic light emitting diode (OLED) technologies and materials for flat panel displays and solid-state lighting. Its primary strategy involves licensing proprietary technologies to manufacturers and selling OLED materials. The Company operates a technology development facility in Ewing, New Jersey, and maintains research agreements with Princeton University, USC, and the University of Michigan.
Key Financial Metrics
| Metric | Three Months Ended Sep 30, 2008 | Nine Months Ended Sep 30, 2008 |
|---|---|---|
| Total Revenue | $2,625,639 | $7,488,056 |
| Net Loss | $(5,302,983) | $(14,702,158) |
| Net Loss Per Share (Basic & Diluted) | $(0.15) | $(0.41) |
| Operating Loss | $(5,832,864) | $(16,869,721) |
| Research & Development Expense | $5,750,361 | $15,955,238 |
| Cash and Cash Equivalents (Sep 30, 2008) | $54,415,132 | |
| Short-term Investments (Sep 30, 2008) | $24,644,704 | |
| Total Liquidity | $79,059,836 | |
| Working Capital | $67,162,634 | |
| Accumulated Deficit | $(176,034,625) |
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased by 14.7% ($451,642) in the quarter and 10.9% ($919,025) for the nine months compared to the same periods in 2007.
- Commercial Revenue: Increased for the nine months ($4.28M vs $3.20M) driven by higher chemical sales and royalties, but decreased slightly in the quarter ($1.32M vs $1.37M).
- Developmental Revenue: Decreased significantly in both periods due to timing of government contract revenue recognition and completion of prior technology development agreements.
- Increased Net Loss: Net loss widened to $5.30M for the quarter (from $2.96M) and $14.70M for the nine months (from $12.72M).
- Driven by a $1.31M increase in operating expenses for the quarter and a $710k increase for the nine months.
- Interest income declined due to lower rates of return on investments ($545k vs $1.11M for the quarter).
- Expense Growth: Research and Development (R&D) expenses increased by $1.18M in the quarter and $390k for the nine months. Increases were attributed to higher payments to PPG Industries, patent costs, personnel costs, and subcontract costs.
- Cash Flow: Net cash used in operating activities improved to $6.80M for the nine months (from $9.45M in 2007), aided by an increase in deferred revenue ($2.2M in fees received) and accounts payable.
Guidance, Outlook, Risks, and Unusual Items
- Liquidity Outlook: Management anticipates sufficient cash and short-term investments ($79.1M total) to meet obligations through at least 2009. However, additional funding may be required for future R&D and patent enforcement, with no assurance of availability given current market conditions.
- Revenue Concentration: One non-government customer (Samsung SDI) accounted for 48% of consolidated revenue for the nine months ended September 30, 2008. 72% of revenue was generated outside North America.
- Legal Contingencies:
- European Patent Oppositions: The Company is defending two key European patents (EP '958 and EP '238) against oppositions filed by Sumitomo/CDT, Merck, and BASF. These patents cover FOLED and PHOLED technologies. Management believes there is a substantial likelihood the patents will be upheld, but outcomes are uncertain.
- Unusual Items:
- Received $2.2M in fees for licenses and joint development in Q3 2008, recorded as deferred revenue.
- Stock-based compensation expense totaled approximately $1.24M for the nine months ended September 30, 2008.
Investor Verification Checklist
- Customer Concentration: Verify the stability of the relationship with Samsung SDI, which represents nearly half of the Company's revenue.
- Patent Litigation Status: Monitor the European Patent Office proceedings regarding EP '958 and EP '238, as a loss could materially impact the Company's core IP portfolio.
- Burn Rate vs. Liquidity: Assess the sustainability of the current cash burn rate (~$6.8M operating cash outflow for nine months) against the $79M liquidity position to confirm the "through 2009" runway.
- R&D Efficiency: Review the correlation between increasing R&D spend ($15.9M for nine months) and the decline in developmental revenue.
- Deferred Revenue Recognition: Track the recognition schedule of the $2.2M in deferred revenue received in Q3 2008 to understand future revenue visibility.